Rocket Pharmaceuticals, Inc.
They an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases.
Last Closing Price
January 24, 2018
Cowen, Evercore ISI
To view the prospectus for Rocket Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277